Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul:136:229-32.
doi: 10.1016/j.jsbmb.2012.09.024. Epub 2012 Sep 28.

1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway

Affiliations
Review

1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway

Yan J Jiang et al. J Steroid Biochem Mol Biol. 2013 Jul.

Abstract

Ultra violet (UV) irradiation, in particular UVB, is the single most important carcinogen for skin tumor formation. UVB induces genetic mutations and immune suppression, which lead to abnormal cell proliferation and eventually tumor formation. Previously studies from our group and others demonstrated that both global and epidermal specific VDR knock out mice are predisposed to either chemical (DMBA)- or long-term UVB-induced skin tumor formation, paralleled by an increase in β-catenin signaling. Using primary cultured human keratinocytes, we further demonstrated that 1,25(OH)2-dihydroxyvitamin D3 (1,25(OH)2D3) suppresses cyclin D1 and Gli1 which are regulated by β-catenin/TCF signaling and have a critical role in epidermal carcinogenesis. Blockage of VDR by siRNA resulted in hyperproliferation of keratinocytes, and increased expression of cyclin D1 and Gli1. In addition, we also showed that 1,25(OH)2D3/VDR directly regulates transcriptional activity of β-catenin/TCF signaling using the -catenin reporter TopGlow. Using K14 driven tamoxifen-induced cre recombinase to delete both VDR and β-catenin in keratinocytes of mice following the first hair follicle cycle, we found that ablation of epidermal specific β-catenin cannot rescue VDR null mice from UVB-induced skin tumor formation. Further study using VDR or β-catenin single null mice is necessary to compare with the data from double null mice. This article is part of a Special Issue entitled 'Vitamin D Workshop'.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Generation of conditional VDR and β-catenin null mice. (A and B) The gene-targeting strategy to delete VDR or β-catenin from keratinocytes by using. Cre-loxP system. (C and D). Decreased expression of VDR or β-catenin mRNA was shown by RT-qPCR. (E) Method of UVB-induced skin tumor formation in K14 driven, TM-induced VDR and β-catenin null mice.
Fig. 2
Fig. 2
Conditional deletion of VDR and β-catenin in epidermis promotes UVB-induced skin tumors. (A) The whole body of DKO mouse shows pigmentation (arrow) and hair, two solid dark-brown tumors (B and D) and one white, exophytic tumor (C). (E) The graph shows the increased rate (%) of skin tumor formation in DKO vs. WT control.

Similar articles

Cited by

References

    1. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. International Journal of Cancer. 1990;46(3):356–361. - PubMed
    1. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes and Control. 1994;5(4):367–392. - PubMed
    1. Neale RE, et al. Basal cell carcinoma on the trunk is associated with excessive sun exposure. Journal of the American Academy of Dermatology. 2007;56(3):380–386. - PubMed
    1. Tremezaygues L, et al. Cutaneous photosynthesis of vitamin D: an evolutionary highly-conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections. Anticancer Research. 2006;26(4A):2743–2748. - PubMed
    1. Gandini S, et al. Meta-analysis of risk factors for cutaneous melanoma: III family history, actinic damage and phenotypic factors. European Journal of Cancer. 2005;41(14):2040–2059. - PubMed

Publication types

MeSH terms